SeraCare Life Sciences Acquires Kirkegaard & Perry Laboratories (KPL)

Permira Partners with Marcucci Family, ADIA and Ampersand to Combine Kedrion and BPL

September 1, 2022

Pharmaceuticals

Funds advised by Permira, in partnership with the Marcucci family and supported by a subsidiary of ADIA and Ampersand Capital Partners, completed the joint acquisition and combination of Kedrion Biopharma and Bio Products Laboratory (BPL) to create a global leader in plasma derivatives and rare disease medicines. The combined company will be headquartered in Italy, generate over €1.1 billion in revenue, and expand its global footprint (including a ~75 US plasma center footprint); Ugo Di Francesco has been appointed CEO effective January 2023.

CURE Pharmaceutical to Acquire Sera Labs for $20 Million

July 30, 2020

Consumer Products

CURE Pharmaceutical entered a memorandum of understanding to acquire 100% of privately held Sera Labs for $20 million in a deal composed primarily of CURE stock, with potential earn-outs of up to an additional $20 million. The acquisition adds Sera Labs' CBD-focused branded portfolio, DTC subscription model and retail/wholesale distribution (over 8,850 U.S. doors) to CURE's cGMP manufacturing and drug-delivery capabilities, with Sera Labs founder Nancy Duitch remaining in a leadership role.

Renovus Capital Partners Acquires KP Labs

July 11, 2023

Professional Services

Renovus Capital Partners acquired KP Labs, a Long Beach–based provider of technology-enabled solutions for corporate law departments, effective June 30, 2023. KP Labs (approximately 40 employees) will join Renovus' legal services portfolio and collaborate closely with HBR Consulting, LAC Group, and Wilson Allen while continuing to operate under its existing brand and leadership.

Olink Proteomics Acquires Agrisera AB

May 12, 2020

Biotechnology

Olink Proteomics AB has acquired Agrisera AB, a Swedish antibody producer, to accelerate development and in‑house production of antibodies for Olink’s PEA immunoassay portfolio. The deal secures supply, lowers cost for customers, and expands Olink’s assay development capabilities by integrating Agrisera’s high-throughput antibody production.

Discovery Life Sciences Acquires QualTek Molecular Laboratories

May 5, 2019

Healthcare Services

Discovery Life Sciences (based in Huntsville, Alabama) has acquired QualTek Molecular Laboratories, a provider of CAP/CLIA-accredited and GLP-capable immunohistochemistry (IHC) laboratories in California and Pennsylvania. The acquisition expands Discovery's histopathology and IHC assay development capabilities and integrates QualTek's services with Discovery's biospecimen, sequencing, flow cytometry and multiomic annotation offerings to accelerate biomarker validation and drug/diagnostic development.

Prairie Capital Recapitalizes Kashi Clinical Laboratories

June 20, 2024

Healthcare Services

Prairie Capital partnered with founder Dr. Zahra Kashi and senior management to recapitalize Kashi Clinical Laboratories, a Portland, Oregon-based accredited clinical laboratory specializing in HLA typing, post-transplant monitoring, genomic sequencing and diagnostic testing. Prairie will support accelerated growth through investments in human capital, sales & marketing, technology and infrastructure, as well as pursuing add-on acquisitions.